AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 282 min read$ALGN

Align Technology, Inc. (ALGN) Q3 Revenue $1.01B, Non-GAAP EPS $2.80

Align Technology reported Q3 2026 revenue of $1.01B, up 1.9% YoY, and non-GAAP EPS of $2.80. Non-GAAP operating margin was 24.4%. The company cited steady aligner growth and improving profitability despite FX and equipment softness.

Original reporting
tradingview.com
Published Oct 28, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Align Technology, Inc. (ALGN) Q3 Revenue $1.01B, Non-GAAP EPS $2.80 — source image
Source · tradingview.com
Decision brief

The 30-second read

$ALGNBullishMed
01

Why it matters

The earnings beat may prompt short‑term buying pressure, but modest top‑line growth tempers enthusiasm.

02

Market read

First‑time earnings disclosure for a mid‑cap U.S. healthcare device maker; relevant for traders monitoring earnings season.

03

What to watch

FX headwinds and equipment softness could pressure future quarters despite current margin gains.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

Align Technology released its Q3 2026 earnings via BusinessWire, highlighting steady aligner growth and margin improvement.

Company-level read

Ticker impact

$ALGNBullishHigh confidence
Context

Q3'26 revenue of $1.014.8B and non‑GAAP EPS $2.80 were disclosed for the first time, providing fresh earnings data.

Expected impact

likely modest upside as investors price in higher profitability and margin expansion

Evidence & confidence

The beat and margin improvement suggest better operating performance, which typically supports a short‑term price rise.

Market effects

Sector

Dental/orthodontic sector may see renewed investor interest due to margin expansion trends.

Regional

U.S. healthcare equities could experience slight lift from the earnings beat.

Global

Limited; primarily impacts U.S. listed Align Technology and its peers.

Counterpoint

What could challenge this read

Revenue growth is only 1.9% YoY; investors may view the beat as insufficient given high valuation.

Key entities

  • company
    Align Technology, Inc.

    Provider of Invisalign clear aligners; ticker ALGN.

Read at source← All news

StoryAlign Technology posts Q3 beat but shares slide on weaker Q4 outlook

Also covered by

2 outlets

Related articles

OCT 28
$ALGNHighAI 8/10

Align Technology stock sheds 5% on weak Q4 revenue outlook

Align Technology (ALGN) reported Q3 2026 earnings beating estimates with $2.80 EPS and $1.02B revenue, but shares fell 5% due to Q4 guidance below expectations. Q4 revenue forecasted at $1.00-$1.02B vs. $1.05B consensus. Full-year revenue expected at $4.11-$4.13B vs. $4.15B estimate. Clear Aligner revenues rose 4.2% YoY, while Imaging Systems revenues declined 7.6% YoY.

investing.com2 min
OCT 28
$ALGNLow

Procter & Gamble's former global healthcare CEO will lead Align on Dec. 31.

Align Technology (ALGN) has appointed Jennifer L. Davis, former CEO of Procter & Gamble’s Global Healthcare, as its new President and CEO effective December 31, 2026. Davis brings 33 years of experience in healthcare and consumer brands. Current CEO Joseph M. Hogan will step down but support the transition. The company also released its third-quarter 2026 financial results and will host a conference call.

stocktitan.net2 min
OCT 28
$ALGNHighAI 8/10

Clear-aligner shipments rose 6.6% to 690,635 cases at Align Technology.

Align Technology reported Q3 2026 revenues of $1.015 billion, up 1.9% YoY. Clear Aligner revenues rose 4.2% YoY to $839.3 million, with shipments up 6.6% to 690,635 cases. Imaging Systems and CAD/CAM Services revenues fell 7.6% YoY. Gross margin was 68.7% (70.4% non-GAAP), and operating margin improved to 16.7% (24.4% non-GAAP). The company repurchased 627.3K shares and expects Q4 revenues between $1.020B and $1.000B.

stocktitan.net3 min